CVE-2018-0189

Description

A vulnerability in the Forwarding Information Base (FIB) code of Cisco IOS Software and Cisco IOS XE Software could allow an unauthenticated, network attacker to cause a denial of service (DoS) condition. The vulnerability is due to a limitation in the way the FIB is internally representing recursive routes. An attacker could exploit this vulnerability by injecting routes into the routing protocol that have a specific recursive pattern. The attacker must be in a position on the network that provides the ability to inject a number of recursive routes with a specific pattern. An exploit could allow the attacker to cause an affected device to reload, creating a DoS condition. Cisco Bug IDs: CSCva91655.

Category

5.3
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.34%
Vendor Advisory cisco.com
Affected: n/a Cisco IOS and IOS XE
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2018-0189?
CVE-2018-0189 has been scored as a medium severity vulnerability.
How to fix CVE-2018-0189?
To fix CVE-2018-0189, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2018-0189 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2018-0189 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2018-0189?
CVE-2018-0189 affects n/a Cisco IOS and IOS XE.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.